Literature DB >> 890329

Treatment of phenprocoumon intoxication with cholestyramine.

T Meinertz, M J Gilfrich, R Bork, E Jahnchen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 890329      PMCID: PMC1631192          DOI: 10.1136/bmj.2.6084.439

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Intoxication with phenprocoumon (marcoumar). Pharmacokinetics and side effects.

Authors:  K Seiler; F Duckert
Journal:  Thromb Diath Haemorrh       Date:  1969-04-30

2.  Interruption of the enterohepatic circulation of phenprocoumon by cholestyramine.

Authors:  T Meinertz; H J Gilfrich; U Groth; H G Jonen; E Jähnchen
Journal:  Clin Pharmacol Ther       Date:  1977-06       Impact factor: 6.875

3.  The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies.

Authors:  E Jähnchen; T Meinertz; H J Gilfrich; U Groth; A Martini
Journal:  Clin Pharmacol Ther       Date:  1976-09       Impact factor: 6.875

4.  Pharmacokinetics of phenprocoumon in man investigated using a gas chromatographic method of drug analysis.

Authors:  N Heni; P Glogner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

  4 in total
  3 in total

1.  [Successful therapy of phenprocoumon poisoning with plasmapheresis].

Authors:  V Gläser; R Seifert
Journal:  Med Klin (Munich)       Date:  1998-03-15

2.  Oral cholestyramine increases elimination of warfarin after overdose.

Authors:  S Renowden; D Westmoreland; J P White; P A Routledge
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-24

3.  Enhanced elimination of warfarin during treatment with cholestyramine.

Authors:  E Jähnchen; T Meinertz; H J Gilfrich; F Kersting; U Groth
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.